[BMJ] From ＆high-risk plaque＊ to high-value care: measuring vulnerability and managing uncertainty |
|
This post will be closed automatically in 2026-06-30 16:51
Reward10points
|
10
Vonoprazan-based versus proton pump inhibitor-based therapy inHelicobacter pylorieradication: an updated systematic review and meta-analysis of randomised trials
30
Cardiopulmonary exercise testing in contemporary cardiology: physiological insights, novel applications and evolving algorithms
10
From ＆high-risk plaque＊ to high-value care: measuring vulnerability and managing uncertainty
10
Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial
50
OP0043TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER 每 DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY
